Broad’s CRISPR patent hit with PGR petition

18-07-2018

Broad’s CRISPR patent hit with PGR petition

BCFC / iStockphoto.com

A CRISPR patent owned by the Broad Institute of Harvard and MIT is “unpatentable for indefiniteness”, according to an agriculture biotech company.


Benson Hill Biosystems, The Broad Institute of Harvard and MIT, Editas Medicine, CRISPR technology, gene-editing, post-grant review, patent invalidation

LSIPR